 | Up a level |
Willis, Thomas A, Hartley, Suzanne, Glidewell, Liz, Farrin, Amanda J, Lawton, Rebecca, McEachan, Rosemary RC, Ingleson, Emma, Heudtlass, Peter, Collinson, Michelle, Clamp, Susan et al (show 7 more authors)
(2016)
Action to Support Practices Implement Research Evidence (ASPIRE): protocol for a cluster-randomised evaluation of adaptable implementation packages targeting 'high impact' clinical practice recommendations in general practice.
IMPLEMENTATION SCIENCE, 11 (1).
25-.
Coen, Oliver, Corrie, Pippa, Marshall, Helen, Plummer, Ruth, Ottensmeier, Christian 
ORCID: 0000-0003-3619-1657, Hook, Jane, Bell, Sue, Sagoo, Gurdeep S, Meads, David, Bestall, Janine et al (show 10 more authors)
(2021)
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.
BMC CANCER, 21 (1).
761-.
Hollinghurst, Joe, Daniels, Helen, Fry, Richard, Akbari, Ashley, Rodgers, Sarah ORCID: 0000-0002-4483-0845, Watkins, Alan, Hillcoat-Nalletamby, Sarah, Williams, Neil, Nikolova, Silviya, Meads, David et al (show 1 more authors)
(2022)
Do home adaptation interventions help to reduce emergency fall admissions? A national longitudinal data-linkage study of 657,536 older adults living in Wales (UK) between 2010 and 2017.
AGE AND AGEING, 51 (1).
afab201-.
Danson, Sarah, Plummer, Ruth, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Hook, Jane, Marshall, Helen, Sagoo, Gurdeep, Meads, David, Bestall, Janine, Velikova, Galina, Gallagher, Ferdia et al (show 6 more authors)
(2019)
A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results.
.